J Korean Continence Soc.
2008 Jun;12(1):19-26.
Efficacy and Safety of Doxazosin GITS over 4 weeks for the Treatment of Non-neurogenic Voiding Dysfunction in Females: Short-term Outcomes
- Affiliations
-
- 1Department of Urology, Sungkyunkwan University School of Medicine, Seoul, Korea.
- 2Department of Urology, College of Medicine, Catholic University of Korea, Kangnam St Mary's Hospital, Seoul, Korea.
- 3Department of Urology, Kwandong University College of Medicine, Cheil General hospital & Women's Healthcare Center, Seoul, Korea.
- 4Department of Urology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea. mschoo@amc.seoul.kr
Abstract
- PURPOSE
We administered doxazosin gastrointestinal therapeutic system (GITS) to women with non-neurogenic voiding dysfunction to evaluate its therapeutic effects.
MATERIALS AND METHODS
Women who had voiding dysfunctions for at least 3 mo were included. Inclusion criteria were age > or =18yr, an International Prostate Symptom Score (IPSS) > or =15, and a maximum flow rate (Qmax) <15mL/sec and/or postvoid residual (PVR) > or =150mL. Patients with neurogenic voiding dysfunction or anatomical bladder outlet obstruction were excluded. All patients were classified according to the Blaivas-Groutz nomogram. After 4 weeks, treatment outcomes were evaluated.
RESULTS
Sixty-two patients were evaluated of mean age 53.8 (32-78)yr. According to the Blaivas-Groutz nomogram, 24 patients had no or mild obstruction (group A) and 38 had moderate or severe obstruction (group B). After treatment, mean IPSS decreased significantly and by more than 5 points in 42 (67.7%). Mean bother scores, Qmax, and PVR also changed significantly. Thirty-seven (59.7%) showed Qmax increases of more than 50%. No significant difference were observed between the groups in terms of IPSS, bother score, Qmax, PVR, micturition frequencies, or functional bladder capacity changes. Adverse effects related to medication were de novo stress urinary incontinence (SUI) (1 case) and underlying SUI aggravation (1 case). By satisfaction assessments, 16 patients (25.8%) were 'mainly satisfied', 31 (50%) were 'slightly satisfied', and 15 (24.2%) were 'dissatisfied'.
CONCLUSION
Doxazosin GITS was found to be effective in female patients with voiding dysfunction regardless of obstruction grade. The alpha-adrenoceptor antagonists should be viewed as initial treatment option for women with a non-neurogenic voiding dysfunction.
Keyword
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- The Efficacy and Safety of Doxazosin GITS in Patients with Benign Prostatic Hyperplasia
- The Effectiveness and Safety of Doxazosin GITS in Hypertension when Added to non-Responders to Monotherapy
- Urotherapy in Non-neurogenic Pediatric Voiding Dysfunction
- 12-month Follow-up Study to Evaluate the Efficacy and Safety of Doxazosin GITS in Patients with Benign Prostatic Hyperplasia
- Clinical Effects of Doxazosin in Essential Hypertension
